dismiss

Come visit us at Booth 901 at AHRMM in Washington, DC
Mark your calendars! On August 2nd is our upcoming LIVE Clean Sweep Auction

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Business Affairs Homepage

GE Healthcare, Jefferson Health partner for $1 billion in efficiencies Eight-year deal will put over 100 GE staffers into 13 network hospitals

Higher upfront hospital inpatient spending reduces Medicare deaths and overall costs Figuring out what constitutes wasteful spending in health care

GE Healthcare acquires consulting firm Novia Strategies Company helped hospitals save hundreds of millions of dollars

Philips to enhance therapeutic offerings via dual acquisitions Innovating interventional procedures with Spectranetics and CardioProlific

Commission alleges Canon's Toshiba Medical acquisition breached EU rules Fine could hit $2.9 billion

New research finds physician-hospital consolidation raises prices Horizontal and vertical integration are at play

Hologic takes FujiFilm to court over patent infringement The suit alleges that five patents in total are infringed upon

Cardiac remote monitoring firms to pay $13 million in fraud resolution Accused of billing Medicare for more costly cardiac monitoring than was needed

Survey finds most physicians view MACRA requirements as 'very burdensome' AMA offers resources to help

Sanford Health, Mid Dakota merger heads to court Would create a group with at least a 75 percent share of physician services

Konica Minolta to acquire Ambry Genetics in $1 billion deal

by Thomas Dworetzky , Contributing Reporter
A Konica Minolta subsidiary is acquiring Aliso Viejo, California's Ambry Genetics in a $1 billion deal, the companies have announced.

The buy will be structured so that Konica Minolta, through Konica Minolta Healthcare Americas – a wholly owned subsidiary of Konica Minolta and Japanese state-backed Innovation Network Corporation of Japan (INCJ) – will pay $800 million to Ambry. Ambry shareholders will get up to $200 million in addition if “certain financial metrics” are met over the next two years, putting the deal's total worth at about $1.0 billion.

Story Continues Below Advertisement

Ventilators Plus -The Easy #1 Choice In Ventilator Sales, Rentals & Support

Our name says it all! Ventilators Plus is a full service depot repair facility offering on-site service as well. We BUY, SELL & RENT all models & also have a FULLY STOCKED parts warehouse available online 24/7. Call 888-889-2992.



The deal is set to close in the third quarter of fiscal year 2017.

“This acquisition is the first in a series of strategic initiatives to secure a leading position for Konica Minolta in precision medicine,” Shoei Yamana said in a statement. “The future of medicine is patient-focused. Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual’s genetic and biochemical makeup, as well as the capabilities to translate that knowledge into information the medical community can use to discover, prevent, and cost-effectively treat diseases. This will not only serve as the future foundation for our health care business, but will pave the way for a fundamental shift in the way medicine is practiced globally.”

Konica Minolta plans to bring Ambry’s capabilities first to Japan, and then to Europe.

The deal is said to be the biggest ever done by Konica, according to Reuters.

Privately held Ambry was founded in 1999 by President and Chairman Charles L.M. Dunlop and CEO Dr. Aaron Elliott.

The company has a suite of genetic tests for inherited and non-inherited diseases, as well as for numerous clinical specialties, including oncology, cardiology, pulmonology, neurology, and general genetics. The firm has performed more than one million genetic tests and identified more than 45,000 mutations in at least 500 different genes.

“We’re excited by this opportunity to combine both our companies’ technologies to unlock new opportunities for precision medicine,” said Dunlop. “As a part of Konica Minolta, we will have the resources, technology, and scale to advance biomedical research and enable the matching of more patients in more countries with specialized medicines that target the underlying cause of their illness.”

Ambry’s capabilities fit in with Konica Minolta’s imaging technology to provide a “comprehensive range of health care diagnostics,” said the companies.
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED